From hospital bench to market: IP, ownership, and access dilemmas in academic ATMPs
Conversation by Ana Nordberg, Lund University and Gabriela Maria Lenarczyk and & Jakob Wested, both CeBIL, University of Copenhagen. Part of the series From Lab to Patient – CREATIC LabtoP Talks.
The CREATIC team are happy to invite you to the CREATIC LabtoP talk webinar series, about bringing ATMP’s from lab to patients. Advanced therapy medicinal products (ATMPs), including cell and gene therapies, are often developed in academic or hospital environments long before a clear commercial pathway exists. These settings are rich in collaboration, public investment, and clinical urgency, but they also raise distinctive challenges for intellectual property and related exclusivities.
This webinar examines how IP questions play out when ATMP innovation is driven by multidisciplinary teams across laboratories, clinics, and partner institutions. We will discuss inventorship and attribution in highly collaborative research and clinical translation; rights ownership and governance (including the practical management of patents, know-how, materials, and data); and the downstream implications for patient access when therapies transition (or do not transition) from non-commercial or pre-commercial pathways into market-oriented development and exploitation.
The session also connects these practical questions to more foundational issues that shape the field: the structure and logic of IP and other immaterial rights/exclusivities, and how they interact with competing policy goals (incentivizing innovation, safeguarding public interests, and ensuring access) and with the scientific and regulatory realities of ATMP development. The webinar will conclude with an open Q&A.
The conversation will take place between Ana Nordberg, Associate Professor, Faculty of law Lund University, Gabriela Maria Lenarczyk, Postdoctoral Fellow, Centre for Advanced Studies in Bioscience Innovation Law (CeBIL) and Jakob Wested, associate professor, Centre for Advanced Studies in Bioscience Innovation Law (CeBIL).
We encourage you to engage actively by submitting your questions in the chat throughout the session. Please join us for this exciting journey into the future of healthcare.
Registration
Register for the webinar (Zoom link will be sent upon registration).
The webinar sound will be recorded and published at a later date.